Shopping Cart 0
Cart Subtotal
USD 0

University of Texas Health Science Center at Houston - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Texas Health Science Center at Houston (UTHealth), a subsidiary of University of Texas System is an educational institution that provides research, education and patient care services. The university operates with schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. It offers clinical research education course that is conducted by clinical trial research professionals and examines the entire clinical trial process. The university's teaching hospitals include Memorial Hermann-Texas Medical Center, Children's Memorial Hermann Hospital and Harris Health Lyndon B. Johnson General Hospital. UTHealth is headquartered in Houston, Texas, the US.

University of Texas Health Science Center at Houston-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Cellenkos and University of Texas Health Science Enter into Research Collaboration Agreement 10

Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 11

University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 12

Licensing Agreements 13

CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 13

Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 14

Cellvation Enters into Licensing Agreement with University of Texas Health Science Center at Houston 15

University of Texas Health Science Center at Houston-Key Competitors 16

University of Texas Health Science Center at Houston-Key Employees 17

University of Texas Health Science Center at Houston-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 20

Government and Public Interest 20

Aug 24, 2018: CPRIT Surpasses USD 2 Billion Milestone with 64 New Grants 20

Mar 08, 2018: UTHealth's Shervin Assassi awarded USD 1.4 million to personalize scleroderma treatments 26

Mar 07, 2018: Slow-release hydrogel aids immunotherapy for cancer 27

Jan 08, 2018: UTHealth, UT Health San Antonio gain USD 6 million to refine cancer-fighting antibody 2018 28

Sep 28, 2017: UTHealth's Jim Zheng awarded USD 5.8 million CPRIT grant to mine cancer data for cures 29

Aug 24, 2017: Research reveals how estrogen regulates gene expression 30

May 08, 2017: UTHealth researchers identify genes in children linked to stress, bipolar disorder 31

Other Significant Developments 32

Mar 13, 2018: Memorial Hermann and UTHealth conduct first sinus surgery in U.S. using augmented reality technology 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Key Facts 2

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

University of Texas Health Science Center at Houston, Deals By Therapy Area, 2012 to YTD 2018 8

University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Cellenkos and University of Texas Health Science Enter into Research Collaboration Agreement 10

Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 11

University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 12

CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 13

Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 14

Cellvation Enters into Licensing Agreement with University of Texas Health Science Center at Houston 15

University of Texas Health Science Center at Houston, Key Competitors 16

University of Texas Health Science Center at Houston, Key Employees 17

University of Texas Health Science Center at Houston, Other Locations 18

University of Texas Health Science Center at Houston, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Texas Health Science Center at Houston, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.